Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature

被引：6

作者：

Taghavi, Maxime ^{[1
,2
]}

Jabrane, Abla ^{[1
]}

Jacobs, Lucas ^{[1
]}

Mesquita, Maria Do Carmo Filomena ^{[1
]}

Demulder, Anne ^{[3
]}

Nortier, Joelle ^{[1
,2
]}

机构：

[1] Univ Libre Bruxelles ULB, Brugmann Univ Hosp, Nephrol & Dialysis Dept, B-1020 Brussels, Belgium

[2] Univ Libre Bruxelles ULB, Fac Med, Lab Expt Nephrol, B-1070 Brussels, Belgium

[3] Univ Libre Bruxelles ULB, Brugmann Univ Hosp, Lab Hematol & Haemostasis LHUB ULB, B-1020 Brussels, Belgium

来源：

ANTIBODIES | 2024年 / 13卷 / 01期

关键词：

antiphospholipid antibodies; antiphospholipid syndrome; arteriovenous fistula; hemodialysis; thrombosis; stenosis; maturation failure; CHRONIC KIDNEY-DISEASE; VASCULAR ACCESS THROMBOSIS; ANTICARDIOLIPIN ANTIBODIES; MAINTENANCE HEMODIALYSIS; LUPUS ANTICOAGULANT; ENDOTHELIAL-CELLS; RISK-FACTORS; THROMBOPHILIA; OCCLUSION; HYPERPLASIA;

D O I：

10.3390/antib13010001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Antiphospholipid antibody (aPL)-persistent positivity is frequent in hemodialysis (HD) patients. Native arteriovenous fistula (AVF) complications such as stenosis and thrombosis are among the most important causes of morbidity and mortality in hemodialysis patients. The association between aPL positivity and AVF thrombosis seems to now be well established. However, whether aPL positivity is associated with other AVF complications, such as maturation failure or stenosis, is not well known. Given the significant impact of AVF failure on patient's prognosis, it is of interest to further investigate this particular point in order to improve prevention, surveillance and treatment, and, ultimately, the patient's outcome. This literature review aims to report the recent literature on aPL-associated native AVF complications.

引用

页数：14

共 76 条

[1]

Adler S, 2001, CLIN NEPHROL, V56, P428

[2] Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis [J].

Almajdi, Anwar ;

Almutairi, Sara ;

Alharbi, Maha .

THROMBOSIS RESEARCH, 2023, 229 :77-85

[3] Antiphospholipid antibodies inend-stagerenal disease: A systematic review andmeta-analysis [J].

Ames, Paul R. J. ;

Merashli, Mira ;

Bucci, Tommaso ;

Pastori, Daniele ;

Pignatelli, Pasquale ;

Violi, Francesco ;

Bellizzi, Vincenzo ;

Arcaro, Alessia ;

Gentile, Fabrizio .

HEMODIALYSIS INTERNATIONAL, 2020, 24 (03) :383-396

[4] Thrombophilic risk factors and ABO blood group profile for arteriovenous access failure in end stage kidney disease patients: a single-center experience [J].

Anapalli, Sunnesh Reddy ;

Devi, Harini N. ;

Sarma, Pvgk ;

Srikanth, Lokanathan ;

Kumar, Siva, V .

RENAL FAILURE, 2022, 44 (01) :34-42

[5] 2023 ACR/EULAR antiphospholipid syndrome classification criteria [J].

Barbhaiya, Medha ;

Zuily, Stephane ;

Naden, Ray ;

Hendry, Alison ;

Manneville, Florian ;

Amigo, Mary-Carmen ;

Amoura, Zahir ;

Andrade, Danieli ;

Andreoli, Laura ;

Artim-Esen, Bahar ;

Atsumi, Tatsuya ;

Avcin, Tadej ;

Belmont, Michael H. ;

Bertolaccini, Maria Laura ;

Branch, D. Ware ;

Carvalheiras, Graziela ;

Casini, Alessandro ;

Cervera, Ricard ;

Cohen, Hannah ;

Costedoat-Chalumeau, Nathalie ;

Crowther, Mark ;

de Jesus, Guilherme ;

Delluc, Aurelien ;

Desai, Sheetal ;

De Sancho, Maria ;

Devreese, Katrien M. ;

Diz-Kucukkaya, Reyhan ;

Duarte-Garcia, Ali ;

Frances, Camille ;

Garcia, David ;

Gris, Jean-Christophe ;

Jordan, Natasha ;

Leaf, Rebecca K. ;

Kello, Nina ;

Knight, Jason S. ;

Laskin, Carl ;

Lee, Alfred I. ;

Legault, Kimberly ;

Levine, Steve R. ;

Levy, Roger A. ;

Limper, Maarten ;

Lockshin, Michael D. ;

Mayer-Pickel, Karoline ;

Musial, Jack ;

Meroni, Pier Luigi ;

Orsolini, Giovanni ;

Ortel, Thomas L. ;

Pengo, Vittorio ;

Petri, Michelle ;

Pons-Estel, Guillermo .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) :1258-1270

[6] Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee Report [J].

Barbhaiya, Medha ;

Taghavi, Maxime ;

Zuily, Stephane ;

Domingues, Vinicius ;

Chock, Eugenia Y. ;

Tektonidou, Maria G. ;

Erkan, Doruk ;

Seshan, Surya V. .

JOURNAL OF RHEUMATOLOGY, 2024, 51 (02) :150-159

[7] Antiphospholipids antibodies and hemodialysis: A frequent association linked to arteriovenous fistula thrombosis [J].

Bataille, Stanislas ;

Burtey, Stephane ;

Decourt, Alexandre ;

Frere, Corinne ;

Henneuse, Agathe ;

Aillaud, Marie-Francoise ;

Morange, Pierre ;

Bardin, Nathalie ;

Duval, Ariane ;

Sallee, Marion ;

Jourde-Chiche, Noemie ;

Gondouin, Bertrand ;

Samson, Laurent ;

Cohen, Julien ;

Berland, Yvon ;

Brunet, Philippe .

NEPHROLOGIE & THERAPEUTIQUE, 2015, 11 (01) :27-33

[8] Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access [J].

Beathard, Gerald A. ;

Lok, Charmaine E. ;

Glickman, Marc H. ;

Al-Jaishi, Ahmed A. ;

Bednarski, Donna ;

Cull, David L. ;

Lawson, Jeffery H. ;

Lee, Timmy C. ;

Niyyar, Vandana D. ;

Syracuse, Donna ;

Trerotola, Scott O. ;

Roy-Chaudhury, Prabir ;

Shenoy, Surendra ;

Underwood, Margo ;

Wasse, Haimanot ;

Woo, Karen ;

Yuo, Theodore H. ;

Huber, Thomas S. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (03) :501-512

[9] Antiphospholipid syndrome infectious origin [J].

Blank, M ;

Asherson, RA ;

Cervera, R ;

Shoenfeld, Y .

JOURNAL OF CLINICAL IMMUNOLOGY, 2004, 24 (01) :12-23

[10]

Bolleke Erjola, 2014, Med Arch, V68, P361, DOI 10.5455/medarh.2014.68.361-363

← 1 2 3 4 5 6 7 8 →